share_log

Vicor Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Vicor Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Vicor 公司剛剛超過了分析師的預期,分析師一直在更新他們的預測
Simply Wall St ·  2023/10/27 03:06

One of the biggest stories of last week was how Vicor Corporation (NASDAQ:VICR) shares plunged 26% in the week since its latest third-quarter results, closing yesterday at US$39.94. It looks like a credible result overall - although revenues of US$108m were in line with what the analysts predicted, Vicor surprised by delivering a statutory profit of US$0.37 per share, a notable 17% above expectations. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

上週最大的新聞之一是維柯公司納斯達克(Sequoia Capital:VICR)股價自最新公佈第三季度業績以來,本週暴跌26%,昨日收於39.94美元。總體而言,這看起來是一個可信的結果-儘管1.08億美元的收入與分析師的預測一致,但Vicor出人意料地實現了每股0.37美元的法定利潤,比預期高出17%。盈利對投資者來說是一個重要的時刻,因為他們可以跟蹤一家公司的表現,看看分析師對明年的預測,以及對該公司的情緒是否發生了變化。我們認為,讀者會發現看到分析師對明年最新(法定)盈利後的預測會很有趣。

See our latest analysis for Vicor

查看我們對Vicor的最新分析

earnings-and-revenue-growth
NasdaqGS:VICR Earnings and Revenue Growth October 27th 2023
NasdaqGS:VICR收益和收入增長2023年10月27日

Taking into account the latest results, the most recent consensus for Vicor from three analysts is for revenues of US$439.6m in 2024. If met, it would imply a satisfactory 5.2% increase on its revenue over the past 12 months. Statutory per share are forecast to be US$1.19, approximately in line with the last 12 months. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$489.7m and earnings per share (EPS) of US$1.45 in 2024. Indeed, we can see that the analysts are a lot more bearish about Vicor's prospects following the latest results, administering a real cut to revenue estimates and slashing their EPS estimates to boot.

考慮到最新的業績,三位分析師對Vicor的最新共識是2024年營收為4.396億美元。如果得到滿足,這將意味著該公司在過去12個月的收入將增長5.2%,令人滿意。預計每股法定收益為1.19美元,與過去12個月基本一致。然而,在最新財報公佈之前,分析師曾預計2024年營收為4.897億美元,每股收益(EPS)為1.45美元。事實上,我們可以看到,在最新業績公佈後,分析師們對維多的前景更加悲觀,實際削減了收入預期,並大幅下調了每股收益預期。

The consensus price target fell 8.4% to US$69.33, with the weaker earnings outlook clearly leading valuation estimates. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. The most optimistic Vicor analyst has a price target of US$75.00 per share, while the most pessimistic values it at US$65.00. With such a narrow range of valuations, the analysts apparently share similar views on what they think the business is worth.

共識目標價下跌8.4%,至69.33美元,較弱的盈利前景顯然領先於估值預期。然而,這並不是我們可以從這些數據中得出的唯一結論,因為一些投資者在評估分析師的價格目標時,也喜歡考慮預期中的價差。最樂觀的Vicor分析師將目標價定為每股75.00美元,而最悲觀的分析師則認為目標價為65.00美元。在如此狹窄的估值範圍內,分析師們顯然對他們認為的企業價值有著相似的看法。

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Vicor's past performance and to peers in the same industry. We would highlight that Vicor's revenue growth is expected to slow, with the forecast 4.1% annualised growth rate until the end of 2024 being well below the historical 10.0% p.a. growth over the last five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 6.8% annually. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Vicor.

這些估計很有趣,但當看到預測如何與Vicor過去的表現和同行業同行進行比較時,描繪一些更寬泛的筆觸可能會很有用。我們要強調的是,Vicor的收入增長預計將放緩,截至2024年底的預測年化增長率為4.1%,遠低於歷史上10.0%的年增長率。過去五年的增長。相比之下,該行業的其他公司(與分析師預測的)相比,預計收入將以每年6.8%的速度增長。因此,很明顯,雖然收入增長預計會放緩,但整個行業的增長速度預計也會快於維高。

The Bottom Line

底線

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. On the negative side, they also downgraded their revenue estimates, and forecasts imply they will perform worse than the wider industry. Furthermore, the analysts also cut their price targets, suggesting that the latest news has led to greater pessimism about the intrinsic value of the business.

最重要的是,分析師們下調了他們的每股收益預期,表明業績公佈後,市場人氣明顯下降。不利的一面是,他們還下調了營收預期,預測表明,他們的表現將遜於整個行業。此外,分析師還下調了他們的目標價,這表明最新消息導致人們對該業務的內在價值更加悲觀。

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Vicor going out to 2025, and you can see them free on our platform here..

根據這一思路,我們認為,業務的長期前景比明年的收益更相關。在Simply Wall St.,我們有全方位的分析師對維柯到2025年的預測,你可以在我們的平臺上免費看到。

You still need to take note of risks, for example - Vicor has 1 warning sign we think you should be aware of.

例如,你仍然需要注意風險--維克多1個個警告標誌我們認為你應該意識到.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫.或者,也可以給編輯組發電子郵件,地址是暗示Wallst.com。
本文由Simply Wall St.撰寫,具有概括性.我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議.它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況.我們的目標是為您帶來由基本面數據驅動的長期重點分析.請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內.Simply Wall St.對上述任何一隻股票都沒有持倉.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論